These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 12354933)
1. Expression of proteinases and inhibitors in human breast cancer progression and survival. Baker EA; Stephenson TJ; Reed MW; Brown NJ Mol Pathol; 2002 Oct; 55(5):300-4. PubMed ID: 12354933 [TBL] [Abstract][Full Text] [Related]
2. The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: relationship to tumour pathology. Baker EA; Leaper DJ Eur J Cancer; 2003 May; 39(7):981-8. PubMed ID: 12706368 [TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis. Fernandez-Garcia B; Eiró N; Marín L; González-Reyes S; González LO; Lamelas ML; Vizoso FJ Histopathology; 2014 Mar; 64(4):512-22. PubMed ID: 24117661 [TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer. Kim GE; Lee JS; Choi YD; Lee KH; Lee JH; Nam JH; Choi C; Kim SS; Park MH; Yoon JH; Kweon SS BMC Cancer; 2014 Dec; 14():959. PubMed ID: 25510449 [TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma. Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787 [TBL] [Abstract][Full Text] [Related]
6. Expression and Clinical Significance of Metalloproteases and Their Inhibitors by Endothelial Cells From Invasive Breast Carcinomas. Cid S; Eiro N; González LO; Beridze N; Vazquez J; Vizoso FJ Clin Breast Cancer; 2016 Aug; 16(4):e83-91. PubMed ID: 27266802 [TBL] [Abstract][Full Text] [Related]
8. Proteolysis in human breast and colorectal cancer. Garbett EA; Reed MW; Brown NJ Br J Cancer; 1999 Sep; 81(2):287-93. PubMed ID: 10496354 [TBL] [Abstract][Full Text] [Related]
9. [The expression of MMPs and TIMPs in human breast cancer tissues and importance of their balance in cancer invasion and metastasis]. Iwata H; Kobayashi S; Iwase H; Okada Y Nihon Rinsho; 1995 Jul; 53(7):1805-10. PubMed ID: 7630023 [TBL] [Abstract][Full Text] [Related]
10. Cobalt chloride-induced hypoxia modulates the invasive potential and matrix metalloproteinases of primary and metastatic breast cancer cells. Fu OY; Hou MF; Yang SF; Huang SC; Lee WY Anticancer Res; 2009 Aug; 29(8):3131-8. PubMed ID: 19661326 [TBL] [Abstract][Full Text] [Related]
11. Study of matrix metalloproteinases and their inhibitors in breast cancer. Vizoso FJ; González LO; Corte MD; Rodríguez JC; Vázquez J; Lamelas ML; Junquera S; Merino AM; García-Muñiz JL Br J Cancer; 2007 Mar; 96(6):903-11. PubMed ID: 17342087 [TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Sakata K; Shigemasa K; Nagai N; Ohama K Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877 [TBL] [Abstract][Full Text] [Related]
13. [The expression of matrix metalloproteinases (MMPs), tissue inhibitor of metalloproteinases (TIMPs) and angiogenesis in relation to the depth of tumor invasion and lymph node metastasis in submucosally invasive colorectal carcinoma]. Jung SA; Yang SK; Kim JS; Shim KN; Im SA; Myung SJ; Jung HY; Yu CS; Kim JC; Hong WS; Kim JH; Min YI Korean J Gastroenterol; 2005 Jun; 45(6):401-8. PubMed ID: 15973074 [TBL] [Abstract][Full Text] [Related]
14. [The role of metalloproteinases and their inhibitors in pancreatic cancer]. Łukaszewicz M; Mroczko B; Szmitkowski M Postepy Hig Med Dosw (Online); 2008 Apr; 62():141-7. PubMed ID: 18414340 [TBL] [Abstract][Full Text] [Related]
15. Expression and distribution of MMPs and TIMPs in human uveal melanoma. Lai K; Conway RM; Crouch R; Jager MJ; Madigan MC Exp Eye Res; 2008 Jun; 86(6):936-41. PubMed ID: 18423620 [TBL] [Abstract][Full Text] [Related]
16. Proteases and their inhibitors in human brain tumours: a review. Rooprai HK; McCormick D Anticancer Res; 1997; 17(6B):4151-62. PubMed ID: 9428349 [TBL] [Abstract][Full Text] [Related]
17. Increased concentration of tissue-degrading matrix metalloproteinases and their inhibitor in complicated diverticular disease. Rosemar A; Ivarsson ML; Börjesson L; Holmdahl L Scand J Gastroenterol; 2007 Feb; 42(2):215-20. PubMed ID: 17327941 [TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database. McGowan PM; Duffy MJ Ann Oncol; 2008 Sep; 19(9):1566-72. PubMed ID: 18503039 [TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression. Yamamoto H; Itoh F; Iku S; Adachi Y; Fukushima H; Sasaki S; Mukaiya M; Hirata K; Imai K J Clin Oncol; 2001 Feb; 19(4):1118-27. PubMed ID: 11181677 [TBL] [Abstract][Full Text] [Related]
20. Proteolysis in human breast cancer. Garbett EA; Reed MW; Stephenson TJ; Brown NJ Mol Pathol; 2000 Apr; 53(2):99-106. PubMed ID: 10889910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]